Skip to main content

Table 1 The pharmacokinetics of ginsenosides evaluated in rats

From: Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies

Ginsenosides

Bioavailibility (%)

Dose (mg/kg)

Refs.

Rb1

4.35

50

[35]

Rg3

2.63

50

[36]

Compound K

35

20

[11]

Rh2

6.4

9

[17]

Re

7.06

10

[37]

Rg1

1.52–6.6

50

[38]

Rh1

1.01

5

[39]

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us